New Guidance on Resmetirom and Semaglutide for MASH

(MedPage Today) — At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on using resmetirom (Rezdiffra) and semaglutide (Ozempic, Wegovy) for metabolic dysfunction-associated steatohepatitis…

Source link : https://www.medpagetoday.com/meetingcoverage/aasldvideopearls/118532

Author :

Publish date : 2025-11-14 18:51:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

New Guidance on Resmetirom and Semaglutide for MASH

The Trend of Unproven Peptides Is Spreading Through Influencers and RFK Jr. Allies

Rapid melt from Antarctica could help preserve crucial ocean current

Related Posts

EU Fluoride Exposure Deemed Safe as Regulators Review Limits

Regional Anesthesia: Key to Better Postoperative Outcomes?

Sooner-than-expected climate impacts could cost the world trillions

First leukaemia patient to get pioneering drug on NHS says it is ‘very sci-fi’

These small lifestyle tweaks can add a year to your life

MicroRNA Tests Eyed for Flagging Heart Transplant Rejection

EU Fluoride Exposure Deemed Safe as Regulators Review Limits

Regional Anesthesia: Key to Better Postoperative Outcomes?

Sooner-than-expected climate impacts could cost the world trillions

First leukaemia patient to get pioneering drug on NHS says it is ‘very sci-fi’

These small lifestyle tweaks can add a year to your life

MicroRNA Tests Eyed for Flagging Heart Transplant Rejection

Experts Alarmed by USPSTF Work Slowdown

‘Dry January’ Offers a Shot of Stigma

Categories

Archives